baber/WOPTO huggingface dataset:
Patent JP-2023159078-A (JP)
Title: Polymer cement composition and polymer cement mortar
Inventor: SHIBAGAKI MASANORI
IPC: C04B28/02
Filed: 2023-07-25
Abstract: To provide a polymer cement composition having excellent spraying performance with controlled dust degree, and excellent thick-spraying properties, dimensional change rate, and compressive strength, and to provide a polymer cement mortar.SOLUTION: A polymer cement composition comprises a binder, a re-emulsified powder resin, a shrinkage reducing agent, and a fine aggregate. A particle size of the fine aggregate is such that a mass percentage of particles having a particle diameter of 5 mm or larger is less than 1 mass% and a mass percentage of particles having a particle diameter of 1.2 mm or larger and smaller than 5 mm is 51 mass% or more and 85 mass% or less based on the total mass of the fine aggregate, a content of the fine aggregate is 120 pts.mass or more and 240 pts.mass or less based on 100 pts.mass of the binder, and a content of the shrinkage reducing agent is 0.1 pts.mass or more and 7.5 pts.mass or less based on 100 pts.mass of the binder.SELECTED DRAWING: None
Patent JP-2023133619-A (JP)
Title: Program, information processor, and control method
Inventor: SHIMODA SHOTA
IPC: A63F13/45
Filed: 2023-08-04
Abstract: To provide a program, an information processor, and a control method for improving convenience of a game.SOLUTION: A program allows a user's information processor to execute a step of storing information regarding a game part that a user is allowed to play, a determination step that determines a mode of a game part as a first mode or a second mode on the basis of a user's operation, and disables continuation or enables continuation in the first mode but enables continuation in the second mode for continuation of play when a game part ends, and an execution stop of executing a game part in a mode determined by the determination step, and continues a game part according to a user's operation when the mode of the game part is the first mode and can continue, and continues the game part automatically when the mode of the game part is the second mode when the game part ends in the execution step.SELECTED DRAWING: Figure 10
Patent JP-2023164529-A (JP)
Title: 送風装置の筐体、および送風装置
IPC: F04D29/44
Filed: 2023-09-07
Abstract: 【課題】部品点数の削減を図ると共に、部品間の位置合わせが容易で、送風ファンの安定 
回転が可能な送風装置を実現する。 
【解決手段】キャビネット（１０）と、ファンモータ（３）と、該ファンモータ（３）の 
駆動力を伝える回転軸（８）と、該回転軸（８）に軸止された送風ファン（４）と、を備 
える送風装置（１）であって、送風ファン（４）を収容するケーシング（１１）およびフ 
ァンモータ（３）を固定するモータカバー（１２）は２分割されており、上半分に相当す 
るケーシング上（１１－１）およびモータカバー上（１２－１）がキャビネット１０と一 
体成形されている。 
【選択図】図１
Patent JP-2023519446-A (JP)
Title: Ｇｉｐ受容体アゴニストペプチド化合物のｑｄ投薬及びその使用
IPC: A61P1/08
Filed: 2021-03-25
Abstract: 本開示は、１日に１回の投薬（ＱＤ）に好適なＧＩＰ受容体アゴニストペプチド化合物であって、前記ペプチド化合物は、ＧＩＰ受容体に対して活性化作用を有する、ＧＩＰ受容体アゴニストペプチド化合物ならびに嘔吐症、または嘔吐症に関連する症状または状態の処置及び／または予防のための医薬としてのＧＩＰ受容体アゴニストペプチドの使用を提供する。具体的には、式（Ｉ）～（Ｖ）のいずれかによって表される配列を含有するＧＩＰ受容体アゴニストペプチドまたはその塩、及びそれを含む医薬が提供される。【選択図】なし
Patent JP-2023520741-A (JP)
Title: ホログラフィックによる遠隔プロクタリングのための、心エコー画像からの医療機器のリアルタイムトラッキング方法
IPC: A61B8/14
Filed: 2021-04-01
Abstract: 本発明は、介入部位で取得された医用画像ストリームを、遠隔ホログラフィックデバイス（１１２）によって可視化する方法に関し、本方法は、Ａ．患者の身体器官の医用画像ストリームを医用取得装置（１０１）によって取得するステップであって、介入中に医療機器が患者の身体器官に挿入される、ステップと、Ｂ．医用画像ストリームをサーバ（１０５）上の仮想マシンにストリーミングするステップ（１０２）と、Ｃ．当該仮想マシン上で実行される、画像ストリームのみに基づくエキスパートアルゴリズム（１０７）によって、医療機器のデジタル位置及び向き、並びに画像ストリーム内の画像の少なくともサブセット上にある少なくとも２つのデジタル解剖学的ランドマークを同定するステップと、Ｄ．医療機器のデジタル位置及び向きを表すグラフィック要素を生成し、かつ当該画像のサブセットにグラフィック要素を重ね合わせることで、重ね合わせ画像ストリームを取得するステップと、Ｅ．重ね合わせ画像ストリームをビデオ信号へと再フォーマットするステップ（１０８）と、Ｆ．可視化を行うために、遠隔ホログラフィックデバイス（１１２）にビデオ信号を送信するステップと、を実行することを含む。
Patent JP-2023535968-A (JP)
Title: 漏れ磁束が抑制された磁性部品
IPC: H01F30/10
Filed: 2021-06-23
Abstract: 本発明は、２つの強磁性ハーフコアを備える磁性部品であって、２つの前記強磁性ハーフコアは、積層されるとともに重ね合わされて強磁性コアを形成し、前記強磁性コアは、３つの脚部（１１、１２、１３）、すなわち、２つの第１脚部（１１、１３）と１つの第２脚部（１２）とを備え、各脚部（１１、１２、１３）は、ギャップにより離れた２つの対面するハーフ脚部から形成され、各脚部（１１、１２、１３）は、前記脚部を形成する前記ハーフ脚部の各々においてそれぞれ巻線方向を有する一次巻線（１１１、１２１、１３１）および二次巻線（１１２、１２２、１３２）を備える磁性部品において、前記第２脚部（１２）において、前記一次巻線（１２１）と前記二次巻線（１２２）、およびそれらの巻線方向は、前記第１脚部（１１、１３）のもの（１１１、１１２、１３１、１３２）に対して逆であることを特徴とする磁性部品に関する。
Patent JP-2023538736-A (JP)
Title: Ｂ群レンサ球菌多糖－タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用
IPC: A61K39/09
Filed: 2021-08-23
Abstract: 本発明は、一般にＢ群レンサ球菌（ＧＢＳ）と称されるストレプトコッカス・アガラクティエ（Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ａｇａｌａｃｔｉａｅ）由来の莢膜多糖（ＣＰ）と、担体タンパク質とを含む免疫原性多糖－タンパク質コンジュゲートに関し、ここで、ＣＰは、血清型Ｉａ、Ｉｂ、ＩＩ、ＩＩＩ、ＩＶ、Ｖ、ＶＩ、ＶＩＩ、ＶＩＩＩおよびＩＸからなる群から選択され、ＣＰは、約６０％超のシアル酸レベルを有する。本発明は、コンジュゲートおよびコンジュゲートを含む免疫原性組成物を作製する方法にも関する。本発明はさらに、対象においてＧＢＳに対する免疫応答を誘発するための、および／または本明細書において開示されている組成物を使用して、対象における侵襲性ＧＢＳ疾患を低減させるもしくは予防するための方法に関する。得られた抗体は、受動免疫療法を介してＧＢＳ感染を治療するまたは予防するために使用することができる。
Patent JP-2023540317-A (JP)
Title: 無機ピクセル封入バリアを有するｏｌｅｄパネルを製造する方法
IPC: H10K59/122
Filed: 2021-03-05
Abstract: 本明細書で説明される複数の実施形態は、有機発光ダイオード（OLED）ディスプレイなどのディスプレイにおいて使用されてよいサブピクセル回路及びサブピクセル回路を形成する方法に関する。デバイスは、複数のサブピクセルを含む。複数のサブピクセルの各サブピクセルは、無機オーバーハング構造がピクセル画定層（PDL）構造上に配置された状態で、隣接するPDL構造によって画定される。各サブピクセルは、アノード、アノード上に配置された有機発光ダイオード（OLED）材料、及びOLED材料上に配置されたカソードを有する。デバイスは、蒸着によってOLED材料及びカソードを堆積させるステップ、及びカソードの上に配置される封入層を堆積させるステップを含む、プロセスによって作製される。【選択図】図１Ａ
Patent JP-2023543749-A (JP)
Title: 接着剤組成物、ゴム補強材および物品
IPC: C09J201/00
Filed: 2021-11-22
Abstract: 本出願は、少なくとも自然由来酸、窒素化合物、およびラテックスを含む接着剤組成物；これを含むゴム補強材および物品に関するものである。
Patent JP-2023542229-A (JP)
Title: 染料固着剤及び直鎖状アルキルベンゼンスルホネートを含有する洗濯洗剤組成物
IPC: C11D1/22
Filed: 2020-09-28
Abstract: 洗濯洗剤組成物は、染料固着剤と、非イオン性界面活性剤系と、Ｃ６～Ｃ２０直鎖状アルキルベンゼンスルホネート（ＬＡＳ）を含む陰イオン界面活性剤系とを含み、非イオン性界面活性剤系と陰イオン界面活性剤系との重量比は少なくとも１．５である。非イオン性界面活性剤系と陰イオン界面活性剤系との重量比が少なくとも１．５であることを特徴とする洗濯洗剤組成物は、着色布地の色を効果的に保護することができる。
Patent JP-2023545854-A (JP)
Title: 改良された７ｘｘｘアルミニウム合金
IPC: C22C21/10
Filed: 2021-10-19
Abstract: 新規の７ｘｘｘアルミニウム合金が開示されている。新規の７ｘｘｘアルミニウム合金は、５．０～９．０重量％のＺｎと、１．３０～２．０５重量％のＭｇと、１．１０～２．１０重量％のＣｕと、ここで、２．５５≦（Ｃｕの重量％＋Ｍｇの重量％）≦３．８５であり、（ｉ）０．０３～０．４０重量％のＭｎおよび０．０２～０．１５重量％のＺｒのうちの少なくとも一つと、ここで、０．０５≦（Ｚｒの重量％＋Ｍｎの重量％）≦０．５０であり、最大０．２０重量％のＣｒと、最大０．２０重量％のＶと、最大０．２０重量％のＦｅと、最大０．１５重量％のＳｉと、最大０．１５重量％のＴｉと、最大７５ｐｐｍのＢと、を含み、残部は、アルミニウム、付随元素、および不純物であることができる。新規の７ｘｘｘアルミニウム合金は、０．５～４．０ｍｍの厚さを有し、少なくとも１５体積％の再結晶粒を含む、７ｘｘｘアルミニウム合金シート製品の形態であってもよい。新規の合金は、強度、伸び、破壊挙動、および耐食性のうちの少なくとも二つの改善された組み合わせを実現することができる。【選択図】図２
Patent JP-2023552048-A (JP)
Title: ハードウェアアクセラレータのためのニューラルアーキテクチャスケーリング
IPC: G06N3/0985
Filed: 2021-07-29
Abstract: ハードウェアアクセラレータ上でニューラルネットワークアーキテクチャをスケーリングするための、コンピュータ読み取り可能な媒体を含む方法、システム、および装置。方法は、訓練データと、ターゲットコンピューティングリソースを指定する情報とを受信することと、訓練データを用いて探索空間のニューラルアーキテクチャ探索を実行して基本ニューラルネットワークのアーキテクチャを識別することとを含む。基本ニューラルネットワークをスケーリングするための複数のスケーリングパラメータ値が識別され得る。この識別は、複数のスケーリングパラメータ値候補を選択することと、複数のスケーリングパラメータ値候補に応じてスケーリングされた基本ニューラルネットワークの性能評価指標を決定することとを繰り返し実行することを含み得、性能評価指標は、レイテンシ目的を含む複数の第２目的に従った性能評価指標である。複数のスケーリングパラメータ値に応じてスケーリングされた基本ニューラルネットワークのアーキテクチャを用いて、スケーリングされたニューラルネットワークのアーキテクチャが決定され得る。
Patent JP-2024502368-A (JP)
Title: 提供システム、および、提供方法
IPC: G06T19/00
Filed: 2021-07-02
Abstract: 仮想的な情報を効率的に提供する。提供システムは、実世界の建物または空間に対応づけられる仮想空間に、地理情報に基づいて時空間コンテンツを設定するための仮想層を備え、仮想層は、少なくとも、建物または空間の目的に基づいて、時空間コンテンツを仮想空間に設定し、時空間コンテンツを、少なくとも、対象物の目的に基づいて少なくとも１つのカテゴリに分類するための分類部と、入力された対象物の目的に適合するカテゴリに属する時空間コンテンツを、対象物へ提供するための提供部とを備える。
Patent JP-2023554190-A (JP)
Title: 乳児用の超音波プローブ保持装置
IPC: A61B8/00
Filed: 2021-12-13
Abstract: 一態様によれば、本明細書は、経泉門イメージング用に乳児の頭部に取り付けるように構成された超音波プローブ保持装置（１０１）であって、前記乳児の前記頭部に接触するように構成され、中央開口（１１５）を有し、超音波プローブを受けるように構成された、ヘッドパッド（１１０）と、中央開口（１２５）を有し、前記ヘッドパッドと協働して、前記乳児の前記頭部に接する表面に対して実質的に垂直な誘導軸（Δ）に沿って前記ヘッドパッドを軸方向に誘導することができるように構成された、パッドスクイーザー（１２０）と、前記乳児の前記頭部に取り付けられるように構成され、前記誘導軸に沿って、前記パッドスクイーザーに下向きの力を加えるように構成された、装置ホルダー（１５０）と、前記装置ホルダーが前記パッドスクイーザーに前記下向きの力を加えたときに、前記パッドスクイーザーと前記ヘッドパッドとの間に反発力を加えるように構成された、反発手段と、を備える、超音波プローブ保持装置に関する。【選択図】図４Ａ
Patent MX-2007001168-A (MX)
Title: Command steer assembly for an articulated vehicle.
Inventor: ATLEY KERRY
IPC: B62D7/04
Filed: 2005-07-29
Abstract: A command steer assembly (15) for an articulated vehicle having a prime mover, and at least one trailer body (1) having a sub-chassis (3) rotatable about a main axis (5), the sub-chassis (3) being supported by a plurality of wheel axles, at least one of the wheel axles being steerage, the command steer assembly including: a steer plate (17) supported for rotation about said main axis and interconnectableby a linkage arrangement (13) to the at least one steerable wheel axle; and a drive arrangement (33) for selectively driving the steer plate for rotation, wherein rotation of the steer plate results in pivotal movement of the at least one steerable wheel axle relative to the sub-chassis.
Patent MX-2007002305-A (MX)
Title: Ring binder mechanism with a sliding hinge plate.
Inventor: CHENG HUNG YU
IPC: B42F13/02
Filed: 2007-02-26
Abstract: A ring binder mechanism for retaining loose-leaf pages comprises a housing and first and second hinge plates supported by the housing for pivoting movement. Ring members are mounted on the hinge plates for movement with the hinge plates between closed and open positions. Hook-shaped formations on fee ends of the ring members lock the ring members together when closed. The first hinge plate is slidable relative to the second hinge plate in a direction along a longitudinal axis of the housing for disengaging the hook-shaped formations and allowing the ring members to open. An actuator may be mounted on the housing for moving the first hinge plate to disengage the hook-shaped formations. In addition, friction buffers may be positioned between the hinge plates for aiding the sliding movement of the first hinge plate relative to the second hinge plate.
Patent MX-2007007280-A (MX)
Title: Cabinet for an air handler unit.
Inventor: CALIENES GEROGE
IPC: B60H3/00
Filed: 2007-06-15
Abstract: A cabinet for an air handling unit includes a cabinet assembly being formed framelessly of a plurality of panel assemblies, each panel assembly being formed of two spaced apart metallic panels embracing an intermediate core and wherein the plurality of panel assemblies provides the structural strength of the cabinet assembly. A method of forming a cabinet for an air handling unit is further included.
Patent MX-2007011675-A (MX)
Title: Apparatus and methods for providing queue messaging over a network.
Inventor: SUSSMAN ADAM
IPC: G06Q30/00
Filed: 2006-03-22
Abstract: Systems and methods are described for processing queue data and for providing queue messaging over a network. An illustrative queuing system includes a first queue configured to hold resource requests from a plurality of users, and program code stored in computer readable memory configured to determine or estimate whether a resource requested by a first resource request submitted by a first requester will be available when the first resource request will be serviced, and to transmit a message over a network to the first requester indicating that the requested resource will not be available when the queued request is serviced if it is estimated or determined that the requested resource will not be available when the first request is serviced.
Patent MX-2007012698-A (MX)
Title: Over molded stator.
Inventor: PURVINES STEPHEN H
IPC: H02K3/24
Filed: 2006-04-11
Abstract: Devices and methods are provided for an improved motor stator. One embodiment for a stator includes a stator section having a first surface and a second surface each surface having a groove extending into the stator section and a slot extending longitudinally between the first and second surfaces. Insulated conductive wires are wound longitudinally around the stator section in the slots to form winding turns contained completely within each groove. A lead frame extends circumferentially along a surface of the stator and the insulated conductive wires couple to the lead frame. A thermoset material is supplied to the stator section to encapsulate the stator section including the lead frame and the insulated conductive wires, and to provide integral coolant flow passages.
Patent MX-2007014643-A (MX)
Title: Branched stent/graft and method of fabrication.
Inventor: ADAMS DANIEL O
IPC: A61F2/00
Filed: 2007-11-22
Abstract: Branched braided stent or graft devices and processes for fabrication of the devices are disclosed in which a trunk portion and two hinge leg portions are fabricated in one piece braided from a single plurality of filaments, whereby the legs contain the full plurality of filaments and the trunk portion contains a subset of the same plurality of filaments. The fabrication process involves braiding the hinged legs on a mandrel while retaining loops of filament between the hinged leg portions for subsequent braiding of the trunk portion of the stent or graft.
Patent MX-2007015475-A (MX)
Title: Wax formulations for lignocellulosic products, methods of their manufacture and products formed therefrom.
Inventor: WANTLING STEVEN J
IPC: C11D3/384
Filed: 2006-06-23
Abstract: The present invention is directed to a wax formulation for use in lignocellulosic products, which impart improved properties such as dimensional stability when the products are exposed to moisture. The wax formulations include a wax and a surface tension/interfacial tension reducing agent comprising one or more of a fluorinated compound having two to six carbon atoms, an alkylphenol alkoxylate or an ethoxylated acetylenic diol.
Patent MX-2008001213-A (MX)
Title: Pharmaceutical formulation of nitrooxyderivatives of nsaids.
Inventor: HOLMBERG CHRISTINA
IPC: A61K9/48
Filed: 2006-06-29
Abstract: The present invention relates to a pharmaceutical formulation comprising: a) one or more NO-releasing NSAID(s) of formula (I); b) one or more surfactants; c) a carbonyl scavenger compound selected from free acid forms, salts, carboxylic acid esters derivatives of a compound of formula (II): H<sub>2</sub>N-(CH<sub>2</sub>)<sub>m</sub>-(C<sub>6</sub>H<sub >4</sub>)-COOH wherein m = 0-10; and d) optionally an oil or semi-solid fat and/ or a short-chain alcohol.
Patent MX-2008006049-A (MX)
Title: Method of isolation and use of cells derived from first trimester umbilical cord tissue.
Inventor: ZURECKI ZBIGNIEW
IPC: B23K3/08
Filed: 2008-05-08
Abstract: A method of isolating a pluripotent cell from human umbilical cord is described herein. The method involves collecting a sample of umbilical cord from fetal tissue obtained at less than 20 weeks of gestation, for example a first trimester umbilical cord. The sample is treated to obtain isolated umbilical cord cells, after which the isolated umbilical cord cells are incubated. Stem cells obtained in this way can be differentiated for use in therapeutic applications.
Patent MX-2008010350-A (MX)
Title: Pharmaceutical formulations.
Inventor: BERRY JULIANNE
IPC: A61K47/14
Filed: 2007-02-07
Abstract: An aspect of the present invention provides for a medicament including a solution containing pleconaril or a pharmaceutically acceptable salt thereof, wherein at least one solvent comprising said solution is a pleconaril-dissolving glyceride oil, and the solution is suitable for inhalation administration as an aerosol mist.
Patent MX-2008012168-A (MX)
Title: 2 -aminopyridine analogs as glucokinase activators.
Inventor: CONDROSKI KEVIN RONALD
IPC: C07D498/04
Filed: 2007-03-23
Abstract: Provided are compounds of formula I that are useful in the treatment and/or prevention of diseases mediated by deficient levels of glucokinase activity, such as diabetes meilitus. Also provided are methods of treating or preventing diseases and disorders characterized by underactivity of glucokinase or which can be treated by activating glucokinase.
Patent MX-2008013862-A (MX)
Title: Device for measuring package size.
Inventor: COOPER RICHARD H
IPC: G01D18/00
Filed: 2007-04-18
Abstract: A package measurement apparatus comprising three measurement devices, one for each dimension. Each measurement device comprises a plurality of signal receptor modules. Each module comprises a row of signal receptor, and a signal energy source. In a first calibration step, the outputs of each receptor are standardized to reference maximums and minimums. In a second calibration step, calibration sets of receptor outputs are created and recorded. During measurement, a measurement set of receptor outputs is obtained and matched with a calibration set of receptor outputs to determine the dimension of an object.
Patent MX-2009002038-A (MX)
Title: Leg cut-out stages of development.
Inventor: COHEN JASON C
IPC: A61F13/15
Filed: 2007-06-05
Abstract: Manufacturers of disposable absorbent articles may produce a wide range of sizes of articles. The design of these articles has generally remained the same as the product increases in size to fit larger and larger users. Generally speaking, the proportions of the articles remain the same in smaller and larger sizes. For example, the longitudinal length of the absorbent core as a percentage of the total longitudinal length of the article may be approximately the same for small, medium, and large sizes.
Patent MX-2009002112-A (MX)
Title: Toothbrush with inclined bristles and pointed bristles.
Inventor: GARBERS CHRISTINE
IPC: A46B9/06
Filed: 2007-08-17
Abstract: A brush head for a toothbrush with bunches (201, 202, 301, 302, 303, 304, 401, 402, 501, 502) of bristles inserted therein, wherein at least one of these bunches (201, 202, 401, 402, 501, 502) of bristles protrudes out of the bristle surface in a perpendicular fashion and at least one of these bunches (301, 302, 303, 304) is inclined, and is characterized in that the inclined bunches (301, 302, 303, 304) of bristles comprise cylindrical bristles, and in that at least some of the bunches (201, 202, 401, 402, 501, 502) which protrude in a perpendicular fashion comprise pointed bristles.
Patent MX-2009004607-A (MX)
Title: A method of administering an antitumor compound.
Inventor: LAFFRANCHI BERNARD
IPC: A61K31/00
Filed: 2007-10-25
Abstract: The present invention provides a method of treating a mammal, including humans, suffering from tumour, comprising administering Compound 1 of the formula A or a pharmaceutically acceptable salt thereof, to said mammal by intravenous infusion, characterised in that Compound 1 is conveniently administered employing particular schedules, infusion times and doses which allow a more efficacious treatment. Compound 1 of formula A is an aurora inhibitor, chemical name N-{5-[(2R)-2-methoxy- 2-phenylethanoyl]-1,4,5,6-tetrahydropyrrolo[3,4-c] pyrazol-3-yl}-4-(4-methylpiperazin-1-yl) benzamide, and the method is preferably for the treatment of patients having solid tumours or hematopoietic malignant tumours. The use of Compound 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient, in the manufacture of a medicament for the treatment of tumours employing particular schedules, infusion times and doses, as well as the use of Compound 1 for treatme nt of tumours in the same manner are also provided.
Patent MX-2009005915-A (MX)
Title: A light source.
Inventor: DEIXLER PETER
IPC: H05B37/02
Filed: 2007-12-07
Abstract: This invention relates to a light source (201) having a plurality of light elements (207) and a control system for controlling the, light elements. The control system comprises a plurality of light element controllers (213), each connected to a respective light element (207), and arranged to obtain light element data; and a bus interface (203), which is connected to the light element controllers (213) via a light source bus (209). The bus interface (203) provides the light element controllers (213) with a general command, and the light element controllers (213) generate light element drive signals on basis of the general command and the light element data.
Patent MX-2009011971-A (MX)
Title: A process for the preparation of an olefin oxide.
Inventor: BASSLER PETER
IPC: C07D301/12
Filed: 2008-04-24
Abstract: The present invention relates to a continuous process for the preparation of an olefin oxide wherein an olefin is reacted with a hydroperoxidein the presence of a catalyst, and wherein the reaction which is carried out in at least three reactors operated in par- allel is controlled by specifically adjusting the catalyst loads in the reactors.
Patent MX-2009013782-A (MX)
Title: Protein kinase inhibitors and methods for using thereof.
Inventor: ZHANG GUOBAO
IPC: C07D403/04
Filed: 2008-06-10
Abstract: The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of Alk, Abl, Aurora-A, B-Raf, C-Raf, Bcr-Abl, BRK, Blk, Bmx, BTK, C-Kit, CSK, C-Src, EphB1, EphB2, EphB4, FLT1, Fms, Flt3, Fyn, FRK3, JAK2, KDR, Lck, Lyn, PDGFRalpha, PDGFRbeta, PKCalpha, SAPK2alpha, Src, SIK, Syk, Tie2 and TrkB kinases.
Patent MX-2010002576-A (MX)
Title: Guanidine-containing compounds useful as muscarinic receptor antagonists.
Inventor: JI YU-HUA
IPC: C07D213/38
Filed: 2008-09-05
Abstract: The invention provides compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein R<sup>1-3</sup>, R<sup>5-7</sup>, a, X, Y, Y', Y'', and Z are as defined in the specification. These compounds are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes for preparing such compounds and methods of using such compounds to, for example, treat pulmonary disorders such as chronic obstructive pulmonary disease and asthma.
Patent MX-2010004659-A (MX)
Title: Refrigerator oil and working fluid composition for refrigerating machine.
Inventor: SHIMOMURA YUJI
IPC: C09K5/04
Filed: 2008-10-20
Abstract: Disclosed is a refrigerator oil characterized by containing an ester of a polyhydric alcohol and a fatty acid containing 50-100% by mole of a fatty acid having 5-9 carbon atoms, not less than 30% by mole of a branched fatty acid having 5-9 carbon atoms, and not more than 40% by mole of a straight chain fatty acid having 5 or less carbon atoms. This refrigerator oil is also characterized by being used together with a fluoropropene refrigerant and/or a trifluoroiodomethane refrigerant. Also disclosed is a working fluid composition for refrigerating machines which is characterized by containing the above-described ester, and a fluoropropene refrigerant and/or a trifluoroiodomethane refrigerant.
Patent MX-2010005693-A (MX)
Title: Engineering enzymatically susceptible proteins.
Inventor: BASU SHIB SANKAR
IPC: C07K14/43
Filed: 2008-11-21
Abstract: The invention provides a synthetic phytase polypeptide which encodes an enzymatically susceptible phytase. Also provided are feed or food products comprising an enzymatically susceptible phytase, and transgenic plants which express the enzymatically susceptible phytase. Further provided are methods for making and using enzymatically susceptible phytases, e.g., a method of using an enzymatically susceptible phytase in feed and food processing.
Patent MX-2010007358-A (MX)
Title: Oral pharmaceutical suspension comprising paracetamol and ibuprofen.
Inventor: ATKINSON HARTLEY
IPC: A61K9/00
Filed: 2008-01-03
Abstract: The present invention relates to an oral pharmaceutical suspension comprising paracetamol and ibuprofen. The invention also relates to a method of treating perioperative or postoperative pain by administering to a subject a therapeutically effective amount of oral pharmaceutical suspension comprising paracetamol and Ibuprofen.
Patent MX-2010008653-A (MX)
Title: Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria.
Inventor: LAURENT FRAISSE
IPC: A61K31/37
Filed: 2009-02-05
Abstract: The invention relates to an association that comprises a salt of bis- thiazolium, a compound of the formula (VI) or a precursor thereof, and artemisinin or a derivative thereof. The invention also relates to a pharmaceutical composition that comprises at least one salt of bis- thiazolium, a compound of the formula (VI) or a precursor thereof, and artemisinin or a derivative thereof. The invention further relates to the use of this combination for preparing a drug for treating or preventing acute malaria. The invention ultimately relates to a kit for treating or preventing acute malaria.